Saar Gill, MD: Combining CAR T-Cell Therapy With Ibrutinib in CLL Patients
1 مناظر
• 07/14/23
0
0
ایمبیڈ
administrator
سبسکرائبرز
Adding ibrutinib to treatment with CAR T-cell therapy was feasible, led to deeper remissions, and reduced the severity of cytokine release syndrome in patients with chronic lymphocytic leukemia.
مزید دکھائیں
فیس بک کے تبصرے
SORT BY-
سرفہرست تبصرے
-
تازہ ترین تبصرے